Mersana Therapeutics Inc (MRSN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 56,391 | 76,972 | 102,287 | 107,750 | 78,868 |
| Marketable Securities | 0 | 0 | 0 | 26,870 | 76,303 |
| Receivables | 168 | 266 | N/A | N/A | 1,000 |
| TOTAL | $59,988 | $80,141 | $106,188 | $136,904 | $160,557 |
| Non-Current Assets | |||||
| PPE Net | 163 | 1,037 | 1,887 | 2,203 | 2,603 |
| Other Non-Current Assets | 2,535 | 3,395 | 4,396 | 5,556 | 6,370 |
| TOTAL | $2,698 | $4,432 | $6,283 | $7,759 | $8,973 |
| Total Assets | $62,686 | $84,573 | $112,471 | $144,663 | $169,530 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 17,351 | 12,500 | 12,500 | 11,458 |
| Accounts payable and accrued liabilities | 2,393 | 2,923 | 4,374 | 4,330 | 2,033 |
| Accrued Expenses | 14,813 | 15,184 | 12,974 | 18,964 | 18,628 |
| Other current liabilities | 0 | 427 | 637 | 640 | 1,057 |
| TOTAL | $43,269 | $59,338 | $58,161 | $62,458 | $68,301 |
| Non-Current Liabilities | |||||
| Long Term Debt | 0 | 0 | 7,901 | 10,950 | 13,999 |
| Deferred Revenues | 23,770 | 20,183 | 23,715 | 22,168 | 31,372 |
| Other Non-Current Liabilities | 0 | 0 | 262 | 1,300 | 2,316 |
| TOTAL | $78,954 | $78,381 | $85,178 | $91,714 | $100,180 |
| Total Liabilities | $122,223 | $137,719 | $143,339 | $154,172 | $168,481 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 4,999 | 4,991 | 4,985 | 4,985 | 4,941 |
| Common Shares | 0 | 0 | 12 | 0 | 12 |
| Retained earnings | -951,517 | -943,972 | -919,676 | -895,553 | -881,436 |
| Other shareholders' equity | 0 | 0 | 0 | 10 | 25 |
| TOTAL | $-59,537 | $-53,146 | $-30,868 | $-9,509 | $1,049 |
| Total Liabilities And Equity | $62,686 | $84,573 | $112,471 | $144,663 | $169,530 |